Phase II (NAVIGATE-AD study) Results of LY3202626 Effects on Patients with Mild Alzheimer's Disease Dementia.

Lo, Albert C; Evans, Cynthia Duggan; Mancini, Michele; Wang, Hong; Shcherbinin, Sergey; Lu, Ming; Natanegara, Fanni; Willis, Brian A

Lo, Albert C; Evans, Cynthia Duggan; Mancini, Michele; Wang, Hong; Shcherbinin, Sergey; Lu, Ming; Natanegara, Fanni; Willis, Brian A.

Afiliación

Lo AC; Eli Lilly and Company, Indianapolis, IN, USA.
Evans CD; Eli Lilly and Company, Indianapolis, IN, USA.
Mancini M; Eli Lilly and Company, Indianapolis, IN, USA.
Wang H; Eli Lilly and Company, Indianapolis, IN, USA.
Shcherbinin S; Eli Lilly and Company, Indianapolis, IN, USA.
Lu M; Avid Radiopharmaceuticals, a Wholly Owned Subsidiary of Eli Lilly and Company, Indianapolis, IN, USA.
Natanegara F; Eli Lilly and Company, Indianapolis, IN, USA.
Willis BA; Eli Lilly and Company, Indianapolis, IN, USA.

J Alzheimers Dis Rep ; 5(1): 321-336, 2021 Apr 29.

Article en En | MEDLINE | ID: mdl-34113788

Palabras clave

Alzheimer's disease; amyloid; neurofibrillary tangles; positron-emission tomography; tau

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: J Alzheimers Dis Rep Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google